Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other ju ...

Exhibit 99.1 press release corescientific.com Core Scientific Announces Fiscal First Quarter 2024 Results Fiscal First Quarter 2024 Highlights • Generated net income of $210.7 million, including a gain on extinguishment of prior obligations of $143.8 million • Produced adjusted EBITDA of $88.0 million • Strengthened the balance sheet, ending the quarter with $98.1 million in cash and cash equivalents • Earned 2,825 self-mined bitcoin, more than any other publicly listed miner in North America • Operated tot ...

Core Scientific, Inc. (NASDAQ:CORZ) Q4 2023 Earnings Conference March 12, 2024 4:30 PM ET Company Participants Steven Gitlin - SVP, Investor Relations Adam Sullivan - CEO Denise Sterling - CFO Conference Call Participants Joe Flynn - Compass Point John Todaro - Needham & Company Lucas Pipes - B. Riley Rosemary Sisson - Odeon Capital Joseph Vafi - Canaccord Genuity Kevin Dede - H.C. Wainwright Jack Chan - Imperial Capital Gregory Lewis - BTIG Darren Aftahi - ROTH MKM Josh Schimmer - Cantor Fitzgerald Operato ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) 网 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal vear ended December 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 □ For the transition period from to Commission file number 001-40046 Core Scientific, Inc. 19904 (Zip Code) (Exact name of registrant as specified in its charter) Delaware 86-1243837 (I.R.S. Emplo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of in ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other jur ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other ju ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 10-K ___________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as spec ...

Core Scientific, Inc. (NASDAQ:CORZ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Steven Gitlin – Senior Vice President-Investor Relations Mike Levitt – Chief Executive Officer Denise Sterling – Chief Financial Officer Conference Call Participants Lucas Pipes – B. Riley Chris Brendler – D.A. Davidson Stephen Glagola – Cowen Kevin Dede – H.C. Wainwright Steven Gitlin Good afternoon, ladies and gentlemen, and welcome to Core Scientific’s Second Quarter Fiscal Year 2022 Earni ...

| --- | --- | --- | |--------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | Second Quarter Fiscal Year | | | | 2022 Earnings Presentation August 11, 2022 | | | | AUG 11, 2022 | | 1 | Legal Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements'' within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use o ...